Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 767 for “"Cancer--Immunotherapy"”.
-
TARGETING PTPN22 FOR CANCER IMMUNOTHERAPY
Immunotherapies have shown remarkable success in cancer treatment. However, diverse tumor-specific immunosuppressive mechanisms dampen response rates highlighting the need for novel immunotherapeutic targets. Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) is a phosphatase specific to …
-
NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY
… to provide synergistic efficacy against primary cancers in animals with just the use of a single wavelength laser at low doses. However, given the limited efficacy of phototherapy towards deep tissue tumours, there is a need to develop combinatorial strategies that goes beyond the treatment of …
-
Dendritic cells in cancer immunotherapy.
Radboud Universiteit Nijmegen, 06 december 2010
-
IMPROVING OUTCOMES FOR CANCER IMMUNOTHERAPY
Cancer immunotherapy has demonstrated immense promise in the past decade. Immune checkpoint therapy has shown unprecedented responses in many cancers; however most patients fail to respond to checkpoint therapy. This highlights the need to develop a better understanding of factors in the tumor …
-
Systems biology models for cancer immunotherapy
Cancer is a complex disease that continues to affect millions of people around the world every year. With ever-improving science and technology, several forms of treatment have been introduced within the past century and continue to be developed so as to provide increasing chances of survival and …
-
Cancer Immunotherapy: Limitations and Potential Strategies
Cancer immunotherapy is a treatment strategy which uses a patient's own immune system to induce or enhance immune responses against cancer. Although immunotherapy has been used for the treatment of a variety of cancers since the early 1900s, it represents the youngest pillar of cancer treatments …
-
Gold Nanovaccine Strategies for Cancer Immunotherapy
Gold nanoparticles have excellent properties for cancer therapeutics because their tunable size and surface chemistry make them customizable for many applications. For immunotherapy applications in particular, we can leverage their natural biodistribution to the spleen and immune cells for …
-
OBESITY AND SEX IN CANCER IMMUNOTHERAPY
… condition often associated with poor outcomes in cancer, yet clinical evidence suggests that obese patients may benefit disproportionately from immunotherapy respect to the lean population. The mechanisms underlying this phenomenon, particularly in relation to sex, remain unclear. In this thesis, …
-
Dendritic Cell Reprogramming for Cancer Immunotherapy
The success of cancer immunotherapy depends on the priming of tumor-specific T and B lymphocytes. However, tumor cells often downregulate antigen presentation and mount an immunosuppressive tumor microenvironment (TME), which excludes immunogenic cells and hinders broad success of cancer …
-
Janus particles designed for cancer immunotherapy
… CD8+ T cells commonly migrate to solid tumors, cancer cells suppress and evade these cells through a variety of intrinsic and extrinsic mechanisms. As a result, recruited cytotoxic T cells are rendered anergic or apoptotic and are thus ineffective at killing cancer cells. Cancer is traditionally …
-
Sialic acid mimetics for cancer immunotherapy
Radboud University, 11 mei 2017
-
Mathematical modeling of prostate cancer immunotherapy
Immunotherapy, by enhancing the endogenous anti-tumor immune responses, is showing promising results for the treatment of numerous cancers refractory to conventional therapies. However, its effectiveness for advanced castration-resistant prostate cancer remains unsatisfactory and new therapeutic …
-
A PEPTIDE HYDROGEL VACCINE FOR CANCER IMMUNOTHERAPY
Immunotherapy, especially immune checkpoint inhibitors, has revolutionized the treatment of cancer. Despite recent progress in cancer biology and drug discovery, immunotherapy benefits only a minority of patients. Resistance, whether primary or acquired, continues to limit the full potential of …
-
Radiographic Challenges and Considerations with Cancer Immunotherapy
… of immune checkpoint inhibitors in advanced lung cancer. MATERIALS AND METHODS: We performed a retrospective analysis of patients with advanced lung cancer treated with immune checkpoint inhibitor monotherapy. Demographic, disease, and treatment data were collected. Serial tumor dimensions were …
-
ARTIFICIAL ANTIGEN PRESENTING CELLS FOR CANCER IMMUNOTHERAPY
Artificial Antigen Presenting Cells (aAPC) are synthetic platforms for T cell activation, made by coupling T cell activating proteins to cell-sized, spherical particles. While this size and shape are chosen to mimic endogenous APC and simplify manufacture, respectively, platforms based on …
-
IPSC-DERIVED IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
… cells (iPSCs) become attractive cell sources in cancer immunotherapy due to the properties of pluripotent differentiation potentials and unlimited proliferation. In this PhD thesis, we explored the potential of iPSC-derived immune cells for cancer immunotherapy. Starting from a healthy donor’s …
-
Phagocytic enhancement of macrophages for cancer immunotherapy
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
-
Engineering pH-responsive biomaterials for cancer immunotherapy
Recent advances in immunotherapy have transformed cancer treatment, while highlighting the complex interactions between the immune system and tumors. For delivery of unstable molecules or immunogenic agents, these therapies often employ nanoformulations to deliver therapeutics to diseased tissue …
Page 1 of 39